Dataset Information


The role of the retinoids in schizophrenia: genomic and clinical perspectives.

ABSTRACT: Signalling by retinoid compounds is vital for embryonic development, with particular importance for neurogenesis in the human brain. Retinoids, metabolites of vitamin A, exert influence over the expression of thousands of transcripts genome wide, and thus, act as master regulators of many important biological processes. A significant body of evidence in the literature now supports dysregulation of the retinoid system as being involved in the aetiology of schizophrenia. This includes mechanistic insights from large-scale genomic, transcriptomic and, proteomic studies, which implicate disruption of disparate aspects of retinoid biology such as transport, metabolism, and signalling. As a result, retinoids may present a valuable clinical opportunity in schizophrenia via novel pharmacotherapies and dietary intervention. Further work, however, is required to expand on the largely observational data collected thus far and confirm causality. This review will highlight the fundamentals of retinoid biology and examine the evidence for retinoid dysregulation in schizophrenia.


PROVIDER: S-EPMC7156347 | BioStudies | 2020-01-01


REPOSITORIES: biostudies

Similar Datasets

1998-01-01 | S-EPMC33865 | BioStudies
1000-01-01 | S-EPMC3754244 | BioStudies
2008-01-01 | S-EPMC2440969 | BioStudies
2018-01-01 | S-EPMC5933457 | BioStudies
2002-01-01 | S-EPMC113761 | BioStudies
2014-01-01 | S-EPMC4064013 | BioStudies
1996-01-01 | S-EPMC1217802 | BioStudies
2013-01-01 | S-EPMC3777752 | BioStudies
2019-01-01 | S-EPMC6561640 | BioStudies
2018-01-01 | S-EPMC5832065 | BioStudies